Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|February 6, 2026
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patientsIngrid A Franken, Steven L C Ketelaars, Carmen Rubio-Alarcón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancerRemond J A Fijneman, Meike de Wit, Maral Pourghiasian, et al.
Communications Biology|April 9, 2022
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissueJob van Riet, Chinmoy Saha, Nikolaos Strepis, et al.
EMBO Reports|April 23, 2021
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2Nathalie Vaes, Simone L Schonkeren, Glenn Rademakers, et al.
Annals of Internal Medicine|November 22, 2017
Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control StudyLinda J W Bosch, Meike de Wit, Thang V Pham, et al.
BMJ Open|March 31, 2021
First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)Robin J Lurvink, Paulien Rauwerdink, Koen P Rovers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 21, 2024
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II)Paulien Rauwerdink, Vincent C J van de Vlasakker, Emma C E Wassenaar, et al.
Gigascience|December 10, 2021
Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing dataYouri Hoogstrate, Malgorzata A Komor, René Böttcher, et al.
Ebiomedicine|December 17, 2025
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastasesNerma Crnovrsanin, J Michiel Zeeuw, Mahsoem Ali, et al.
Nature|May 31, 2019
Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
Pageof 10